Stockreport

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial [Yahoo! Finance]

PainReform Ltd. - Ordinary Shares  (PRFX) 
PDF pharmaceutical company focused on the reformulation of established therapeutics, today announced the receipt of partial topline data from its contract research organizat [Read more]